Biocompatibility of silk-tropoelastin protein polymers

Biomaterials

Volumn 35, Issue 19, 2014, Pages 5138-5147

  Liu, Hongjuan ^a   Wise, Steven G ^a,b   Rnjak Kovacina, Jelena ^c,d   Kaplan, David L ^c   Bilek, Marcela M M ^a   Weiss, Anthony S ^a   Fei, Jian ^e,f   Bao, Shisan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c Tufts University   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e TONGJI UNIVERSITY   (China)

^f Shanghai Research Center for Model Organisms   (China)

Author keywords

IL 1 ; Inflammation; Silk; Subcutaneous implant; Tropoelastin

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CELL PROLIFERATION; FUNCTIONAL POLYMERS; SILK; SURGERY;

BIOLOGICAL PROPERTIES; BIOMATERIAL IMPLANTATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY RESPONSE; NEO-VASCULARIZATION; SUBCUTANEOUS IMPLANTS; TROPOELASTIN;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; COLLAGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KI 67 ANTIGEN; SILK FIBROIN; TROPOELASTIN; POLYMER; SILK;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN FIBROBLAST; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; MATERIALS TESTING; METABOLISM;

MUS; MUS MUSCULUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MATERIALS TESTING; MICE; POLYMERS; SILK; TROPOELASTIN;

EID: 84898457699     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.024     Document Type: Article

References (55)

1. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
2. Onuki Y., Bhardwaj U., Papadimitrakopoulos F., Burgess D.J. A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol 2008, 2:1003-1015.
3. Weber B., Emmert M.Y., Schoenauer R., Brokopp C., Baumgartner L., Hoerstrup S.P. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 2011, 33:307-315.
4. Collins T.J. ImageJ for microscopy. Biotechniques 2007, 43:25-30.
5. Daamen W.F., Veerkamp J.H., van Hest J.C.M., van Kuppevelt T.H. Elastin as a biomaterial for tissue engineering. Biomaterials 2007, 28:4378-4398.
6. Wise S.G., Weiss A.S. Tropoelastin. Int J Biochem Cell Biol 2009, 41:494-497.
7. Wise S.G., Mithieux S.M., Weiss A.S. Engineered tropoelastin and elastin-based biomaterials. Adv Protein Chem Struct Biol 2009, 78:1-24.
8. Rodgers U.R., Weiss A.S. Integrin alpha v beta 3 binds a unique non-RGD site near the C-terminus of human tropoelastin. Biochimie 2004, 86:173-178.
9. Wise S.G., Byrom M.J., Waterhouse A., Bannon P.G., Weiss A.S., Ng M.K. A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties. Acta Biomater 2011, 7:295-303.
10. Vepari C., Kaplan D.L. Silk as a biomaterial. Prog Polym Sci 2007, 32:991-1007.
11. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 2005, 26:147-155.
12. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
13. Hu X., Wang X., Rnjak J., Weiss A.S., Kaplan D.L. Biomaterials derived from silk-tropoelastin protein systems. Biomaterials 2010, 31:8121-8131.
14. Hu X., Cebea P., Weiss A.S., Omenettoa F., Kaplan D.L. Protein-based composite materials. Mater Today 2012, 15:208-215.
15. Li L., Fei Z., Ren J., Sun R., Liu Z., Sheng Z., et al. Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic mice. BMC Immunol 2008, 9:49.
16. Li L., Liu Z., Yang X., Yan H., Bao S., Fei J. Bioluminescence imaging for IL-1beta expression in experimental colitis. J Inflamm 2013, 10:16.
17. Anderson J.M. Biological responses to materials. Ann Rev Mater Res 2001, 31:81-110.
18. Wu W.J., Vrhovski B., Weiss A. Glycosaminoglycans mediate the coacervation of human tropoelastin through dominant charge interactions involving lysine side chains. J Biol Chem 1999, 274:21719-21724.
19. Rockwood D.N., Preda R.C., Yucel T., Wang X.Q., Lovett M.L., Kaplan D.L. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 2011, 6:1612-1631.
20. Cogswell J.P., Godlevski M.M., Wisely G.B., Clay W.C., Leesnitzer L.M., Ways J.P., et al. NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 1994, 153:712-723.
21. Tavakoli N.N., Harris A.K., Sullivan D.R., Hambly B.D., Bao S. Interferon-gamma deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet. Int J Mol Med 2012, 30:545-552.
22. An F., Gong B., Wang H., Yu D., Zhao G., Lin L., et al. miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 2012, 17:702-716.
23. Fang B.A., Dai A., Duflou J., Zhang X., Puranik R., Bao S. Age-related inflammatory mediators in coronary artery disease (II). Int J Cardiol 2013, 168:4839-4841.
24. Brodbeck W.G., Voskerician G., Ziats N.P., Nakayama Y., Matsuda T., Anderson J.M. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A 2003, 64:320-329.
25. John M., Oltmanns U., Fietze I., Witt C., Jung K. Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis. Exp Lung Res 2002, 28:55-68.
26. Zambuzzi W.F., Paiva K.B., Menezes R., Oliveira R.C., Taga R., Granjeiro J.M. MMP-9 and CD68(+) cells are required for tissue remodeling in response to natural hydroxyapatite. J Mol Histol 2009, 40:301-309.
27. Luttikhuizen D.T., van Amerongen M.J., de Feijter P.C., Petersen A.H., Harmsen M.C., van Luyn M.J. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials 2006, 27:5763-5770.
28. Tan J., Saltzman W.M. Topographical control of human neutrophil motility on micropatterned materials with various surface chemistry. Biomaterials 2002, 23:3215-3225.
29. Tang L. Mechanisms of fibrinogen domains: biomaterial interactions. J Biomater Sci Polym Ed 1998, 9:1257-1266.
30. Hu W.J., Eaton J.W., Ugarova T.P., Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001, 98:1231-1238.
31. Anderson J.M., McNally A.K. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Immunopathol 2011, 33:221-233.
32. Jenney C.R., Anderson J.M. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 2000, 49:435-447.
33. Keselowsky B.G., Collard D.M., Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 2005, 102:5953-5957.
34. Keselowsky B.G., Collard D.M., Garcia A.J. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials 2004, 25:5947-5954.
35. Schmidt D.R., Kao W.J. The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function. Biomaterials 2007, 28:371-382.
36. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
37. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
38. Bird S., Zou J., Wang T., Munday B., Cunningham C., Secombes C.J. Evolution of interleukin-1beta. Cytokine Growth Factor Rev 2002, 13:483-502.
39. Miller K.M., Anderson J.M. Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Mater Res 1988, 22:713-731.
40. Miller K.M., Huskey R.A., Bigby L.F., Anderson J.M. Characterization of biomedical polymer-adherent macrophages: interleukin 1 generation and scanning electron microscopy studies. Biomaterials 1989, 10:187-196.
41. Anderson J.M. Inflammatory response to implants. ASAIO Trans 1988, 34:101-107.
42. Jones J.A., McNally A.K., Chang D.T., Qin L.A., Meyerson H., Colton E., et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008, 84:158-166.
43. Jones J.A., Chang D.T., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007, 83:585-596.
44. Li M.C., He S.H. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 2004, 10:620-625.
45. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
46. Bonfield T.L., Colton E., Marchant R.E., Anderson J.M. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Mater Res 1992, 26:837-850.
47. Krause T.J., Robertson F.M., Liesch J.B., Wasserman A.J., Greco R.S. Differential production of interleukin 1 on the surface of biomaterials. Arch Surg 1990, 125:1158-1160.
48. Hwang J.J., Jelacic S., Samuel N.T., Maier R.V., Campbell C.T., Castner D.G., et al. Monocyte activation on polyelectrolyte multilayers. J Biomater Sci Polym Ed 2005, 16:237-251.
49. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
50. Liu Y., Min D., Bolton T., Nube V., Twigg S.M., Yue D.K., et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: response to Muller, et al. Diabetes Care 2009, 32:e137.
51. Mithieux S.M., Rasko J.E., Weiss A.S. Synthetic elastin hydrogels derived from massive elastic assemblies of self-organized human protein monomers. Biomaterials 2004, 25:4921-4927.
52. Mithieux S.M., Tu Y., Korkmaz E., Braet F., Weiss A.S. In situ polymerization of tropoelastin in the absence of chemical cross-linking. Biomaterials 2009, 30:431-435.
53. Bax D.V., Wang Y., Li Z., Maitz P.K., McKenzie D.R., Bilek M.M., et al. Binding of the cell adhesive protein tropoelastin to PTFE through plasma immersion ion implantation treatment. Biomaterials 2011, 32:5100-5111.
54. Rnjak-Kovacina J., Wise S.G., Li Z., Maitz P.K., Young C.J., Wang Y., et al. Tailoring the porosity and pore size of electrospun synthetic human elastin scaffolds for dermal tissue engineering. Biomaterials 2011, 32:6729-6736.
55. Numata K., Kaplan D.L. Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev 2010, 62:1497-1508.